Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.

Nickel allergy can result in both cutaneous and systemic manifestations, and can range from mild to severe symptoms. A severe form of this allergy is the Systemic nickel allergy syndrome ...

In our study, the patients with the best clinical outcomes were the ones who had strong or extreme reactions on patch testing. In contrast, only 2 of 4 patients with questionable or weak patch ...

How do you determine which patients with atopic dermatitis are appropriate candidates for ruxolitinib cream, particularly in the context of step therapy requirements and prior treatment failures?

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. The current treatment options for ...

If you’re struggling with dry skin this winter, we know it can feel like an uphill battle to keep your skin moisturized. Throw dermatitis into the mix, and the frustration compounds. No one ...

Ruxolitinib cream shows comparable efficacy to systemic therapies in reducing disease severity in moderate atopic dermatitis, with significant BSA reduction over 7.4 months. Abrocitinib ...